If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.
If you’re an employee looking for your AccessHope benefit, call 800.423.3232 and select Option 1.
AccessHope, LLC, a company expanding access to world‑class cancer expertise, announced that it has completed more than 20,000 cancer case reviews since its founding, expanded its clinical trials capabilities and grown its national network to more than 340 subspecialty oncologists.
Read moreMore than 30% client growth and new clinical trials ... Read more
Employers nationwide can now offer NCI-designated comprehensive cancer center ... Read more
AccessHope Launches New Service to Help More Cancer ... Read more
03/02/26 - BenfitsPRO
In this latest BenefitsPRO article, our Chief Strategy and Growth Officer Peter Bridges outlines how employers can support the entire care journey, from diagnosis through treatment and into survivorship. Read more
02/13/26 - Fierce Healthcare
In this Fierce Healthcare article, Lantern announced a new partnership with AccessHope to expand its cancer care navigation platform. Read more
12/16/25 - OncoDaily
In OncoDaily, John Hennessy, associate principal at Payer Sciences, rounds up top posters from this year’s ASCO Quality Care Symposium. He highlights AccessHope’s research on how remote expert oncology opinions can help bridge socioeconomic and geographic barriers to optimal cancer care. Read more
03/20/25 - Johns Hopkins Medicine
Harnessing the power of artificial intelligence (AI) will enable new strategies for tackling cancer in a collaborative venture that brings together team science and vast data resources. As part of the new, national Cancer AI Alliance (CAIA), scientists from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the Johns Hopkins Whiting School of Engineering will develop projects centered on using AI to enable precision cancer care, building better approaches to detect, intercept and treat cancers, considering each patient’s unique history and treatment path. Read more
03/17/25 - Dana-Farber Cancer Institute
Dana-Farber researchers have uncovered an alarming reality: children from low-income households are more likely to experience cancer relapse and face lower survival rates compared to their more privileged peers, despite receiving treatment on highly standardized clinical trials at top academic centers. Read more
03/13/25 - Emory Healthcare
A study conducted by executive director of Winship Cancer Institute of Emory University, found a new drug that shows remarkable promise in treating patients with a specific type of advanced lung cancer. Read more
AccessHope Surpasses 10 Million Members as It Scales National Access to Expert Cancer Care
